Description: The SOA Research Institute and LIMRA have completed the most up-to-date study of variable annuity contract owner behavior. Learn more about this vital resource for actuaries working with annuities.

Description: The Society of Actuaries Individual Disability Experience Committee has completed their study of incidence experience for the period 2006-2014 comparing trends to the 2013 IDI Valuation Table (2013 IDIVT) base incidence rates. Included is the report and pivot table.

Description: The COVID-19 pandemic has had an impact on all aspects of daily life and its impact extends to how disability incidence may play out in the future. Product profitability will be shaped by how morbidity patterns, interest rate levels and other key drivers will play out into the future. In this session, our panel will discuss COVID’s impact on IDI morbidity experience as observed over the past 18 months, offer comparisons and insights in light of other insurance lines of business, and share emerging information on the on-going effects of Long COVID. Highlights will also include how regional differences and implications for insurers as the industry moves further into the COVID vaccine era.

Description: The most recent U.S. population data released by the Centers for Disease Control and Prevention (CDC) and from the U.S. Census at year-end 2021 includes the first ten months of the COVID-19 pandemic in the U.S. While we know the pandemic has had significant impacts on both the U.S. population and insured population mortality, we also see increased mortality due to many other non-COVID causes of death. Where are the biggest changes and what does this non-COVID excess mortality mean over the next few years? Take part as an expert panel hosts an interactive discussion to examine data from general population as well as from both individual life and group life experience studies to explore how these changes might spur innovation in underwriting, assumption setting and pricing.

Description: Almost half of recent FDA approvals have been for orphan drugs. This trend is expected to continue in 2023. Orphan drugs are priced more than 30 times higher than non-orphan drugs, therefore their cost burden in aggregate has the potential to overwhelm the budgets of payers, especially that of smaller health plans. Hear how the cost impact analysis for smaller health plans require different considerations than for a larger health plan when modeling the impact of rare diseases.

Description: CMS provides ACOs with monthly claims data for members, including their medical visits and ACO program eligibility. This data can be divided into Membership and Claims tables through the ETL process. However, when calculating PMPY at specific levels of detail using these tables, issues arise due to unrelated dimensions, leading to inaccurate and understated results. This article presents a solution to this problem by utilizing Tableau's data blending capabilities.

Description: Dive into the approach and adverse effects of the regulation of 3rd parties and advance consent by the proposed NAIC Consumer Privacy Protection Model Law #674. The regulation of 3rd parties through their contracts with insurers will be explained. Specifics will be provided on the negative effect on companies contracting with 3rd parties. The requirement for advance consent for use of personal data for actuarial and marketing studies will be explained, and two potential solutions will be presented.

Description: Come prepared for an engaging workshop where you will have the opportunity to share thoughts on and work through a variety of questions concerning how actuaries must adapt to account for newer underwriting and distribution practices. Seating will be limited for this workshop focused on life actuaries who price and set assumptions for products impacted by new underwriting tools and processes such as accelerated underwriting (AU) or direct-to-consumer (DTC) distribution.

Description: The SOA Research Institute and LIMRA have completed the most up-to-date study of universal life lapse and surrender data. Learn more about this vital resource for actuaries working with individual life insurance products.

Description: This study aims to explore the evolution of and trends in how consumers from younger generations understand, investigate, and purchase private insurance plans.